ruzurgi- amifampridine tablet
jacobus pharmaceutical company,inc - amifampridine (unii: ru4s6e2g0j) (amifampridine - unii:ru4s6e2g0j) - ruzurgi is indicated for the treatment of lambert-eaton myasthenic syndrome (lems) in patients 6 to less than 17 years of age. ruzurgi is contraindicated in patients with: - a history of seizures [see warnings and precautions (5.1)] - hypersensitivity to amifampridine or another aminopyridine [see warnings and precautions (5.2)] risk summary there are no data on the developmental risk associated with the use of ruzurgi in pregnant women. animal studies to assess the potential adverse effects of amifampridine on embryofetal development have not been conducted. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. the background risk of major birth defects and miscarriage for the indicated population is unknown. risk summary there are no data on the presence of amifampridine or the 3-n-acetyl-amifampridine metabolite in human milk, the effects on the breastfed infant, or the effects on mi
thidiazuron
profeng australia pty ltd - thidiazuron - unknown - thidiazuron uron active 0.0 - active constituent
toltrazuril
abbey laboratories pty ltd - toltrazuril - unknown - toltrazuril antiprotozoal-coccidiostat active 0.0 - active constituent
ozurdex dexamethasone 700 microgram intravitreal implant
abbvie pty ltd - dexamethasone, quantity: 700 microgram - implant - excipient ingredients: polyglactin - ozurdex is indicated for the treatment of:,- diabetic macular oedema (dme),- macular oedema due to branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo).,- non-infectious uveitis affecting the posterior segment of the eye. ozurdex is indicated for the treatment of diabetic macular oedema (dme).
zurampic- lesinurad tablet, film coated
ironwood pharmaceuticals, inc. - lesinurad (unii: 09erp08i3w) (lesinurad - unii:09erp08i3w) - lesinurad 200 mg - zurampic is indicated in combination with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a xanthine oxidase inhibitor alone [see clinical studies (14) ]. zurampic is not recommended for the treatment of asymptomatic hyperuricemia. zurampic should not be used as monotherapy [see warnings and precautions (5.1) ]. the use of zurampic is contraindicated in the following conditions: - severe renal impairment (eclcr less than 30 ml/min), end stage renal disease, kidney transplant recipients, or patients on dialysis [see use in specific populations (8.6) ] - tumor lysis syndrome or lesch-nyhan syndrome [see use in specific populations (8.8) ]. risk summary there are no available human data on use of zurampic in pregnant women to inform a drug-associated risk. no teratogenicity or effects on fetal development were observed in embryo-fetal development studies with oral administration of lesinurad to pregnant rats
ruzurgi amifampridine 10 mg tablet bottle
lacuna pharma pty ltd - amifampridine, quantity: 10 mg - tablet - excipient ingredients: magnesium stearate; colloidal anhydrous silica; sodium starch glycollate type a; calcium hydrogen phosphate dihydrate; microcrystalline cellulose - ruzurgi is indicated for the treatment of lambert-eaton myasthenic syndrome (lems) in adults and children aged 6 years and above.
proterra thidiazuron 500 cotton defoliant
proterra pty ltd - thidiazuron - suspension concentrate - thidiazuron uron active 500.0 g/l - growth regulator - cotton - pre harvest | except crop-seed production - defoliation of cotton plants | defoliation aid
accensi thidiazuron 500 cotton defoliant
accensi pty ltd - thidiazuron - suspension concentrate - thidiazuron uron active 500.0 g/l - growth regulator - cotton - pre harvest | except crop-seed production - defoliation of cotton plants | defoliation aid
oztec thidiazuron 500 sc liquid cotton defoliant
oztec rural pty limited - thidiazuron - suspension concentrate - thidiazuron uron active 500.0 g/l - growth regulator
relyon thidiazuron 500 cotton defoliant
nutrien ag solutions limited - thidiazuron - suspension concentrate - thidiazuron uron active 500.0 g/l - growth regulator